Global HIV Drugs Market 2010-2014

NEW YORK, Dec. 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global HIV Drugs Market 2010-2014

http://www.reportlinker.com/p0707335/Global-HIV-Drugs-Market-2010-2014.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

TechNavio's analysts forecast the Global HIV Drugs market to reach US$15.5 billion by 2014. One of the key factors contributing to this market growth is the increase in the use of highly active antiretroviral therapy. The Global HIV Drugs market has also been witnessing the need for novel HIV drugs. However, the expiration of patents of key drugs in 2010 could be a challenge to the growth of this market.

TechNavio's report, Global HIV Drugs Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions. It covers the segments such as Hospitals, Patient Diagnostic Centers, and Point-of-Care Centers. The report also analyzes the Global HIV Drugs market landscape and its growth prospects. Further, it includes a discussion of the key vendors operating in this market.

Key vendors dominating this market include Gliead Sciences Inc., Bristol-Myers Squibb Co., Abbott Laboratories, ViiV Healthcare.

Key questions answered in this report:

What will the market size be in 2014 and at what rate will it grow?

What key trends is this market subject to?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the opportunities and threats faced by each of these key vendors?

What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Vendor Landscape

06. Buying Criteria

07. Market Growth Drivers

08. Drivers and their Impact

09. Market Challenges

10. Market Trends

11. Key Vendor Analysis

11.1 Gilead Sciences Inc.

11.2 Bristol-Myers Squibb Co.

11.3 Abbott Laboratories

11.4 ViiV Healthcare

12. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global HIV Drugs Market 2010–2014 (US$ billions)

Exhibit 2: Global HIV Drugs Market by Geographical Segmentation 2010

Exhibit 3: Patients Suffering from HIV by Geographical Segmentation 2010

Exhibit 4: Global HIV Drugs Market by Key Customer Segmentation 2010

Exhibit 5: Global HIV Drugs Market by Key Vendor Segmentation 2010

To order this report:

Drug and Medication Industry: Global HIV Drugs Market 2010-2014

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker